Merck

All You Need To Know About Merck’s Covid Pill Molnupiravir

Molnupiravir was developed for the treatment of Influenza. According to whistleblower complaint Molnupiravir has mutagenic properties and may change your DNA. Now, Molnupiravir has been repurposed for COVID-19. Merck has entered into agreements with Indian manufacturers and has also announced $5 million of donations to enter into Indian market. Here

Read More »
The $35 billion vaccine market

The $35 Billion Vaccine Market

The $35 billion vaccine market has grown sixfold over the past two decades. The industry has consolidated to four big players that account for about 85% of the market — British drugmaker GlaxoSmithKline, French pharmaceutical company Sanofi, and U.S.-based Merck and Pfizer. EXCLUSIVE: Coronavirus Bioweapon – How China Stole Coronavirus From Canada

Read More »